Medicinal plants: Potential to fight superiority diseases

Laxmipriya Padhi

Abstract


Since the beginning of human civilization, medicinal plants have been used by mankind for its therapeutic value. The history of medicine and pharmacy begins with Hippocrates, the father of medicine. He mentioned nearly 400 plant samples used as medicinal substances. In earlier times some plants were venerated because they were known to have valuable properties. No one sought to discover how or why they had this power; it was an undisputed fact and seemed to border on magic. Presently one third of all pharmaceuticals are of plant origin. It is estimated that one in seven of all existing plant has medicinal or curative power, but only if carefully chosen and properly prepared. Scientific analysis of medicinal plants has led to the discovery of many important modern drugs and some experts believe that plants may well hold the secret to combat superiority diseases. Recently the constituents of medicinal plants have gained importance in the treatment of AIDS, malaria and tuberculosis. At present, use of plants are the inspirations for a new drug discovery, whichever by combination of novel compounds or substances for healing diseases. Innovative study is required for evaluating plants from the traditional system of medicine, endow with us with clues as to how these plants can be used in the treatment of diseases with suitable experiments. This review offers information’s on use of plants based drugs in modern medicine. Additional it describes the significance of medicinal plants in infectious and superiority diseases.

Keywords


Medicinal plants; Traditional knowledge; Infectious diseases; Antibiotic resistance

References


Franklin TJ, Snow GA. The development of antimicrobial agents past, present and future in biochemistry of antimicrobial action. Chapman and Hall Londan, New York, 1989, pp. 1-19.

Davis BD, Dulbecco R, Eisen HN, Ginsberg HS, Wood RBJr., McCarty M. Microbiology, Harper and Row publisher Hagerston, New York, 1973, pp. 148.

Koch R. Gsudhtsamte, 1881, 1, 234.

Hammond SM, Lambert PA. Antibiotics and antimicrobial action. In: Arnolds, E. (ed.), Antibiotics and antimicrobial action, London, 1978, pp. 4-9.

Fleming A. On the antibacterial action of cultures of a Penicillium, with a special reference to their use in the isolation of B- influenze. British Journal of Experimental Pathology, 1929, 10, 226-236.

Chain E, Florey HW, Gardner AD, Heatley NG, Jenning MA, Orrewing J, Sanders AG. Lancet, 1940, 2, 226-228.

Waksman SA, Lechevalier HA. Neomycin, a new antibiotic active against streptomycin resistant bacteria, including tuberculosis organisms. Science, 1949, 109, 305-307.

Hazen EL, Brown R. Fungicidin, an antibiotic produced by a soil actinomycetes. Proceedings of Society of Experimental Biology and Medicine, 1951, 76, 93-97.

Gold W, Stout HA, Pagano JF, Donovick R. Antibiotics A, 1956, 579-586.

Oxford A, Raistrickh E, Simonarpt. Studies in the biochemistry of micro-organisms. Griseofulvin, a metabolic product of Penicillium griseofulvum Dierckx. Biochemistry Journal, 1939, 33: 240.

Holt RJ. The imidazole injection. In: Speller, D.C.E. (ed.), Antifungal chemotherapy, Wiley, New York, 1980, pp. 108-147.

Haq I. Medicinal plants. Hamdard Foundation Press, Pakistan, 1983.

Cotton CM. Ethnobotany-Principles and applications. John Wiley and Sons Ltd., Chisester, UK, 1996.

Cox PA. The ethnobotanical approach to drug discovery: strengths and limitations. In: Ethnobotany and the search for the new drugs, John Wiley and Sons, England, 1994, pp. 25-36.

World Health Organization, The WHO recommended classification of pesticides by hazard and guidelines to classification 2000-2202 (WHO/PCS/01.5). International Programmed on Chemical Safety, World Health Organization, Geneva, 2000.

World Chiropractic Alliance. 2000, http://www.worldchiropracticalliance.org

World Health Organization, General guidelines for methodologies on research and evaluation of traditional medicine. World Health Organization, Geneva, 2002.

Fauci AS. HIV and AIDS: 20 years of Science. Nature Medicine, 2003, 9: 839-843.

Robbers J, Speedie M, Tyler V. Pharmacognosy and pharmaco-biotechnology. Williams and Wilkins, Baltimore, 1996, pp. 1-14.

World Health Organization, Global Tuberculosis Report. WHO Report, Geneva, 2009.

Pablos-Mendez A, Gowda DK, Frieden TR. Controlling multidrug resistant tuberculosis and access to expensive drugs: a rational framework. Bulletin of the World Health Organization, 2002, 80(6), 489-500.

Cantrell CL, Franzblau SG, Fischer NH. Antimycobacterial plant terpenoids. Planta Medica, 2001, 67, 685-694.

Newton SM, Lau C, Gurcha SS., Besra GS, Wright CW, et al. The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis. Journal of Ethnopharmacology, 2002, 79, 57-67.

Okunade AL, Elvin-Lewis MPF, Lewis WH. Natural antimycobacterial metabolites: current status. Phytochemistry, 2004, 65, 1017-1032.

Copp BR. Antimycobacterial natural products. Natural Product Reports, 2003, 20, 535-557.

Asres K, Bucar F, Kartnig T, Witvrouw M, Pannecouque C, de Clercq E. Antiviral activity against human immunodeciency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants. Phytotherapy Research, 2001, 15, 62-69.

Zhan L, Yue ST, Xue YX, Attele AS, Yuan CS. (2000). Effects of qian-kun-nin, a Chinese herbal medicine formulation, on HIV positive subjects: A pilot study. American Journal of Chinese Medicine, 2000, 28(3-4): 305-312.

Saxena S, Pant N, Jain DC, Bhakuni RS. Antimalarial agents from plant sources. Current Science, 2003, 85, 1314-1329.

Frederich M, Tits M, Angenot L. Potential antimalarial activity of indole alkaloids. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008, 102, 11-19.

Kaur K, Jain M, Kaur T, Jain R. Antimalarials from nature. Bioorganic Medicine Chemistry, 2009, 17, 3229-3256.

Batista R, Silva ADJ, Oliveira. Plant-derived antimalarial agents: New leads and efficient phytomedicines. Part II. Non-alkaloidal natural products. Molecules, 2009, 14, 3037-3072.

MacKinnon S, Durst T, Arnason JT, Angerhofer C, Pezzuto J, Sanchez-Vindas PE, et al. Antimalarial activity of tropical Meliaceae extracts and gedunin derivatives. Journal of Natural Products, 1997, 60, 336 -341.

Masaba SC. The antimalarial activity of Vernonia amygdalina Del (Compositae). Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000, 94, 694 /695.

Madureira MCD, Martins AP, Gomes M, Paiva J, Cunha APD, Rosario VD. Anti-malarial activity of medicinal plants used in traditional medicine in S. Tome and Principe islands. Journal of Ethnopharmacology, 2002, 81: 23-29.

Bagavan A, Rahuman AA, Kaushik NK, Saha D. In vitro antimalarial activity of medicinal plant extracts against Plasmodium falciparum. Parasitology Research, 2011, 108, 15-22.

UNESCO. Culture and Health, Orientaion texts, World Decade for Cultural Development 1988-1997. Document CLT/DEC/PRO-1996, UNESCO, Paris, 1996, pp. 129.

UNESCO FIT/504-RAF-48 Terminal Report: Promotion of ethnobotany and the sustainable use of plant resources in Africa. UNESCO, Paris, 1998, pp. 60.

Manavalan ARS, Manian K. Medicinal and aromatic plants diversity and utility : Conservation and utilisation of médicinal and aromatic plants. Allied Publisher Ltd., New Delhi, 2001.

Kumar S, Singh J, Saha NC, Ranjan V. Indian medicinal and aromatic plants facing genetic erosion. Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India, 1997.

Singh J, Singh AK, Pravesh R. Proceedings of first NIM on Medical Aromatic Plants, 2003, pp. 50-58.

Ved DK, Anjana M, Shankar D. Current Science, 1998, 75: 341-344.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Annals of Pharma Research

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.